Sarepta stock jumps as FDA accepts DMD drug applications
Investing.com Gold reports: Sarepta stock jumps as FDA accepts DMD drug applications. Full body text was unavailable at ingest time, so this brief is based on headline context.
Investing.com Gold reports: Sarepta stock jumps as FDA accepts DMD drug applications. Full body text was unavailable at ingest time, so this brief is based on headline context.